CEO Viewpoint: Dr Chris Ting on lab leadership in the COVID-19 era
As founder and group CEO of Pathology Asia Holdings (PAH), Dr Christopher Ting manages one of Southeast Asia’s leading clinical laboratory networks. With operations in Singapore, Malaysia, Vietnam and Australia, his company is playing an important role in the regional fight against the COVID-19 pandemic. He is also launching initiatives and making investments to ensure its […]
CEO Viewpoint: Dr Chris Ting on lab leadership in the COVID-19 era Read More »